Syndax Pharmaceuticals files initial beneficial ownership statement for CFO Aaron Ondrey
SNDX•Syndax Pharmaceuticals CFO Aaron Ondrey filed an initial beneficial ownership statement dated Nov. 12, 2026.
1. Ownership filing
Syndax Pharmaceuticals Chief Financial Officer Aaron Ondrey filed an initial statement of beneficial ownership dated Nov. 12, 2026.
